HeartSciences Inc. Common Stock(HSCS)

Stock quote, options chain, IV rank, technicals, AI analysis, and institutional ownership.

HSCS iron condor setups HSCS expected move HSCS IV rank history HSCS Fibonacci levels HSCS insider trading

Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.

HSCS — —
Snapshot
Info
Industry (SIC)
FINANCE SERVICES (6199)
Exchange
XNAS
Market Cap
$0.0B

HeartSciences Inc is an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease. Its objective is to improve healthcare by making it a far more valuable cardiac screening tool, particularly in frontline or point-of-care clinical settings. It is developing a suite of AI-ECG diagnostic solutions for use in any healthcare setting, either via the MyoVista Insights cloud-platform using one of the millions of ECG devices currently in clinical use or via the MyoVista wavECG Device.

Summary
—
composite
—
No summary data available for this symbol yet.

Each spoke is this symbol's rank within its sector (0–100; the dotted ring marks the sector median at 50). Higher is more constructive for a long. One spoke — News sentiment — is an absolute reading, not a sector rank. Grayed spokes have no data. A fuller shape is a summary, not a recommendation.

Chart
Seasonality
MonthAvg ReturnYears of Data
Jan +30.76% 4
Feb -13.41% 4
Mar -14.37% 4
Apr -6.89% 4
May -10.60% 4
Jun -1.87% 5
Jul -15.10% 5
Aug +2.79% 5
Sep +6.94% 5
Oct +2.81% 4
Nov -14.63% 4
Dec -3.29% 4
Technical Indicators

Quick-reference for reading the values below. Indicators combine to confirm a view — no single one is a trade signal on its own.

Trend Indicators
  • SMA 20 / 50 / 200 — price above = uptrend, below = downtrend. SMA 50 crossing SMA 200 is the golden/death cross.
  • EMA 12 / 26 — faster-reacting averages; 12 above 26 is short-term bullish.
  • MACD — bullish when MACD > signal (green badge), bearish when below. Divergence from price often precedes reversals.
  • ADX (14) — trend strength regardless of direction. <20 range, 20–25 weak trend, 25–50 trend, >50 strong trend.
  • +DI / −DI — +DI > −DI favors bulls; the reverse favors bears. Read alongside ADX.
Momentum Oscillators
  • RSI (14) — <30 oversold, >70 overbought. 40–60 is neutral; trending names can stay extreme.
  • Stochastic %K / %D — <20 oversold, >80 overbought. %K crossing %D is an early momentum signal.
  • Williams %R — inverted scale: <−80 oversold, >−20 overbought.

Oscillators work best in range-bound markets; in strong trends they give premature reversal signals.

Volume & Volatility
  • Bollinger Bands — price at upper band = overbought, lower = oversold. Narrow bands (squeeze) often precede expansion.
  • OBV — cumulative volume; rising OBV confirms uptrend, falling OBV confirms downtrend. Divergence from price is a warning.
  • Vol SMA 20 / Vol ROC — today's volume vs. 20-day average. Positive ROC with price move = conviction.
  • ATR / True Range — average daily $ move; sizing and stop-loss reference.
  • HV 20 / 30 / 60 — realized (historical) volatility. Compare to IV on the options cards: IV > HV = rich premium.

Confluence matters: trend + momentum + volume agreeing carries far more weight than any single indicator. For how these feed the spread scanner score, see the algorithm docs →

Trend Indicators

SMA 20: $3.92
SMA 50: $2.99
SMA 200: $2.63
Current: $4.73
EMA 12: $4.32
EMA 26: $3.80
MACD: 0.5199 | Signal: 0.0496
BULLISH
ADX (14): 46.17
STRONG TREND
+DI: 32.22
−DI: 12.41

Momentum Oscillators

RSI (14): 66.13
NEUTRAL
Stoch %K: 70.58
Stoch %D: 70.76
Williams %R: -26.00

Volume & Volatility

BB Upper: $5.28
BB Lower: $2.57
NEUTRAL
OBV: 135,522,270
Vol SMA 20: 150,922
Vol ROC: -2.99%
ATR: $0.46
True Range: $0.37
HV 20: 137.7%
HV 30: 127.7%
HV 60: 109.4%

Data Summary

Data Points: 500
Last Updated:
Date Range: 2024-09-27T00:00:00 – 2026-09-25T00:00:00
AI Analysis

LLM Stock Analysis Report

Executive Summary

Overall Assessment: NEUTRAL (Confidence Level: 6/10)

Key Drivers:

  • Technical indicators suggest a neutral trend, with no clear uptrend or downtrend
  • Recent news headlines are mixed, but generally positive

Primary Risks:

  • Regulatory issues, particularly with the FDA Breakthrough Device Designation for MyoVista Insights AI-ECG Algorithm for Detecting Aortic Stenosis
  • Competition in the ECG device market

Investment Thesis: HSCS has a unique AI-powered ECG algorithm that could potentially disrupt the medical device industry. However, regulatory hurdles and competition pose significant risks.

Recent News Sentiment Impact: The recent news headlines have had a neutral impact on the stock price, with no clear catalysts driving significant moves.

Technical Analysis

Trend Direction: Neutral (Short-term: neutral, Medium-term: neutral, Long-term: bullish)

Support/Resistance Levels:

  • SMA 20: $3.04
  • SMA 50: $3.00
  • Upper Bollinger Band: $3.37

Momentum Signals:

  • RSI (14): 39.77 (neutral)
  • MACD: -0.08 / Signal: -0.04 / Histogram: -0.04 (bearish)

Volume Analysis: Volume trends suggest institutional interest, with a high volume rate of change.

News & Sentiment Analysis

Recent Headlines Summary:

  1. HeartSciences Inc. (HSCS) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now - Nasdaq (Nasdaq, 2025-10-21) - NEUTRAL
  2. HeartSciences faces Nasdaq delisting over equity shortfall - Investing.com (Investing.com, 2025-03-21) - NEUTRAL
  3. HeartSciences Inc. Reports Second Quarter Fiscal 2026 Financial Results and Progress on MyoVista Insights and wavECG Device Submissions - Quiver Quantitative (Quiver Quantitative, 2025-12-15) - POSITIVE
  4. UK university bets on AI ECG to train future NHS heart specialists - Stock Titan (Stock Titan, 2026-02-05) - NEUTRAL
  5. HeartSciences Receives FDA Breakthrough Device Designation for MyoVista Insights AI-ECG Algorithm for Detecting Aortic Stenosis - Investing News Network (Investing News Network, 2025-06-05) - NEUTRAL
  6. HeartSciences (HSCS) Stock Forecast and Price Target 2026 - MarketBeat (MarketBeat, 2024-05-16) - NEUTRAL

Sentiment Assessment: Aggregate news sentiment is NEUTRAL.

Catalyst Identification:

  • FDA Breakthrough Device Designation for MyoVista Insights AI-ECG Algorithm
  • Earnings reports and company updates

Market Narrative: The recent news headlines have generally been positive, but the overall trend remains neutral. The market is waiting for more significant catalysts to drive price movements.

Risk & Volatility Assessment

Beta Interpretation: Beta of 0.43 indicates a low risk relative to the broader market.

Volatility Regime: Current volatility levels are lower than historical averages, suggesting a relatively calm market.

Options Market Signals:

  • IV rank: Not available
  • Put/call ratios: Not available
  • Unusual activity: None

Downside Protection: Support levels include SMA 20 and Bollinger Band Lower. Risk management considerations should focus on these levels.

Market Context & Positioning

Sector Performance: HeartSciences operates in the medical device sector, which has been relatively stable recently.

Institutional Activity: Volume trends suggest institutional interest, with a high volume rate of change.

Correlation Analysis: The stock moves relatively independently of the broader market (R-squared interpretation).

Relative Valuation: Position within trading range, with no clear overbought or oversold conditions.

Key Levels & Action Items

Critical Price Levels:

  • SMA 20: $3.04
  • Upper Bollinger Band: $3.37

Breakout/Breakdown Levels:

  • SMA 50: $3.00 (breakout)
  • Lower Bollinger Band: $2.70 (breakdown)

Time-Sensitive Catalysts:

  • FDA Breakthrough Device Designation for MyoVista Insights AI-ECG Algorithm
  • Earnings reports and company updates

Risk Management: Stop-loss levels should be set at SMA 20 and Bollinger Band Lower. Position sizing considerations should focus on these levels.

I hope this analysis meets your requirements!

Generated
News
Options Activity
Loading options activity...
Spread Scanner GPU
Full Algorithm Docs ↗

Each spread is ranked by a composite score built in three stages. Full documentation →

Stage 1 — Base Score (GPU scanner)

score = P(profit) × (credit / spread_width)
P(profit) from short leg delta (1 − |delta|), penalised above 85%. Credit uses mid-price to handle illiquid chains fairly.

Stage 2 — Skew Adjustment (±25% cap)

RR and BF (30-delta) from the persisted per-symbol skew snapshot — wing strikes picked by real greeks.delta, not a moneyness proxy. Put skew boosts bull puts, penalises bear calls. High butterfly boosts iron condors. Calendars are skew-neutral.

Stage 3 — Technical Overlay (±50% cap, 5 groups)
Group 1 · Directional Bias (±0.25)
  • RSI <40 bullish / >60 bearish
  • MACD crossover + histogram trend
  • Price vs SMA 50 & SMA 200
Group 2 · Momentum (±0.10)
  • Stochastic %K <20 / >80
  • Williams %R <−80 / >−20
Group 3 · Volatility (up to −0.25 / +0.15)
  • Blended ATR + straddle expected-move penalty
  • Bollinger Band signal (+ counter-trend penalty)
  • BB width — vol contraction boost for ICs
Group 4 · IV Regime (±0.15)
  • IV rank ≥ 75 → strong boost for credit spreads
  • IV rank < 25 → penalty (selling cheap vol)
Group 5 · Liquidity (penalty up to −0.10)
  • Min open interest across all legs
  • OI < 100 → −0.10 · OI < 500 → −0.05

score = base_score × skew_multiplier × tech_multiplier
Both multipliers are shown per spread. Beta is informational only — ATR already captures realized vol. Full algorithm documentation →

Enter a ticker to scan for optimal spread opportunities.

Evaluates all bull put, bear call, iron condor, and calendar spread combinations using GPU-accelerated analysis.

Skew (Wing IV − ATM IV)
DTE:
Wing Δ:
Metric:
Wing vs ATM
IV(put wing) − IV(ATM), in vol points

How much the OTM put trades above (or below) the at-the-money strike. Measures the height of the put-side tail relative to ATM — i.e. how expensive crash insurance is on this name.

  • Positive (typical) — wing IV > ATM IV. Standard equity put skew: portfolios bid up crash protection, so OTM puts trade richer than ATM.
  • Near zero or negative (unusual) — wing IV ≤ ATM IV. Flat or inverted put side. Common when there's no fear demand, in tightly mean-reverting names, or right after an earnings catalyst clears.
  • Percentile vs own 3-yr history: high = wings rich (good time to sell wing premium); low = wings cheap (good time to buy protection).
  • Not directional — high or low wings don't predict up or down moves. It's a price tag on tail insurance, not a forecast.
Risk Reversal
IV(call wing) − IV(put wing), equal delta on each side

Which side of the smile is the market paying up for? Measures the tilt of the surface — call skew vs put skew at matched deltas.

  • Negative (typical) — puts richer than calls. Standard equity behavior: hedging demand makes puts carry a premium. Most large-caps sit in the −1 to −5 vol-point range.
  • Strongly negative (< −5 pts) — heavy downside hedging, elevated fear, or an upcoming catalyst (earnings, FDA, macro event). Worth flagging.
  • Positive — calls richer than puts. Unusual for equities; signals bullish momentum, short-squeeze positioning, or takeover/M&A speculation.
  • Near zero — symmetric surface. Market sees roughly equal up/down risk. Rare for large-caps; more common in commodities and FX.
Reading them together

Wing-vs-ATM tells you how expensive the tails are. Risk Reversal tells you which side is favored. Combined:

  • High wing percentile + deeply negative RR → strong put bid; stress or major event priced in. Owning protection costs a premium; selling put premium is dangerous.
  • Low wing percentile + near-zero RR → complacency; insurance cheap and balanced. Good environment to add cheap downside hedges.
  • Positive RR + elevated wings → call-side fear-of-missing-out; common in squeeze setups. Upside calls expensive, downside puts not bid.
14 DTE / 10d —
— pts EXTREME
ATM — / Wing —
30 DTE / 10d —
— pts EXTREME
ATM — / Wing —

Percentile is the rank of today's reading within ~3 years of this symbol's own history. High percentile = wings are rich relative to history; not a directional signal. Skew is read off the chain in real time, not from CBOE SKEW.

Volatility Surface

Enter a ticker to render the implied volatility surface.

Volatility Smile

Enter a ticker to render the implied volatility smile.

IV Rank (7 DTE)
IV Rank (30 DTE)
Straddle Price (30 DTE)
Beta Analysis
Beta (1Y vs SPY)
0.12
Correlation (SPY)
1.6%
R²
0.00
Ann. Volatility
103.3%
SPY Volatility
13.0%

Low volatility - stock moves less than market

Beta & Alpha Over Time
Institutional Ownership (13F)
Latest filings — 2026-06-30

Institutional managers with $100M+ AUM file Form 13F-HR quarterly, due 45 days after quarter end. Holdings are reported gross at quarter-end market value — they are a snapshot, not a real-time position.

  • Shares — long equity positions in this name, aggregated across share classes.
  • Calls / Puts — notional value of long call / put exposure where this ticker is the underlying.
  • % of Float — holder's reported shares divided by the latest diluted shares outstanding. Sums above 100% indicate large custodian / prime broker positions where the same shares are reported by multiple filers.
  • Custodian badge — filers with more than 5,000 holdings are typically broker-dealers / custodians reporting customer-held shares, not active managers.

Each filer is counted once at its latest 13F-HR filing. New filings are ingested on a weekly cadence.

18 filers172,280 shares$443.21K value
# Filer Shares Value % of Total % of Float Period
1 TFB Advisors LLC 29,740 $74.65K 16.84% — 2026-06-30
2 GEODE CAPITAL MANAGEMENT, LLC Custodian 23,049 $57.85K 13.05% — 2026-06-30
3 VANGUARD GROUP INC Custodian 18,556 $57.34K 12.94% — 2025-12-31
4 Astoria Strategic Wealth, Inc. 18,927 $47.51K 10.72% — 2026-06-30
5 VANGUARD CAPITAL MANAGEMENT LLC 17,968 $45.10K 10.18% — 2026-06-30
6 VANGUARD FIDUCIARY TRUST CO 17,239 $43.27K 9.76% — 2026-06-30
7 Tradition Wealth Management, LLC 16,819 $42.22K 9.53% — 2026-06-30
8 CITADEL ADVISORS LLC Custodian 14,488 $36.37K 8.20% — 2026-06-30
9 CITIGROUP INC Custodian 5,859 $14.71K 3.32% — 2026-06-30
10 UBS Group AG Custodian 5,812 $14.59K 3.29% — 2026-06-30
11 Tower Research Capital LLC (TRC) Custodian 1,568 $3.94K 0.89% — 2026-06-30
12 BlackRock, Inc. Custodian 750 $1.88K 0.42% — 2026-06-30
13 Federation des caisses Desjardins du Quebec Custodian 700 $1.76K 0.40% — 2026-06-30
14 OSAIC HOLDINGS, INC. Custodian 650 $1.63K 0.37% — 2026-06-30
15 Allied Private Wealth LLC 120 $327 0.07% — 2026-06-30
16 WELLS FARGO & COMPANY/MN Custodian 25 $63 0.01% — 2026-03-31
17 Caitong International Asset Management Co., Ltd 8 $20 <0.01% — 2026-06-30
18 Financial Management Professionals, Inc. 2 $5 <0.01% — 2026-06-30
# Filer Notional Value % of Total Period
# Filer Notional Value % of Total Period
Insider Activity
Latest: 2026-07-09
Form 4 filings — insider beneficial-ownership changes by officers, directors, and 10%+ holders. Filed within 2 business days of transaction.
Filed Reporter Role Action Shares Avg Price Net $ Link
2026-07-09 Danielle Watson See Remarks Grant (A) +25,000 RSU — EDGAR
2026-06-24 Andrew Simpson See Remarks Award (A) +425,000 — EDGAR
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (described in filing footnote — typically 401(k), trust, inheritance) · W = will/inheritance. Only P / S codes carry directional signal.
Insider Holdings
1 insider · @ $4.73
Officers, directors, and 10%+ owners ranked by current disclosed exposure (shares × today's price). Shares are direct + indirect (via trusts / LLCs / spouse). Excludes unvested RSU and option grants — those aren't beneficially owned until vest.
# Insider Role Shares Disclosed Exposure Lifetime OM Net Filings Last Filed
1 Andrew Simpson See Remarks 499,382 $2.36M $0 1 2026-06-24
Lifetime OM Net = signed sum of open-market buys (P) and sells (S) over their career; excludes grants, tax withholdings, and dispositions to issuer. A large negative number is normal for long-tenured executives — they've sold compensation grants over many years.
Notice of Proposed Sale (Form 144)
Latest: 2025-07-29
Last 30d: 0 filings  ·  Last 90d: 0 filings

What is Form 144? A notice of intent to sell restricted or control stock under Rule 144. Affiliates (officers, directors, 10%+ owners) and holders of restricted shares must file Form 144 when planning to sell more than 5,000 shares or $50,000 in any 3-month rolling window.

How it relates to Form 4: Form 144 is filed before the trade (up to 90 days in advance); Form 4 is filed within 2 business days after the trade executes. Not every Form 144 results in a sale — the filer may cancel or delay. Look for the corresponding Form 4 on the Insider Activity card to confirm a sale actually happened.

10b5-1 plans: Trades made under a pre-scheduled Rule 10b5-1 plan are not discretionary — they execute automatically on dates set months earlier, regardless of news. High 10b5-1 percentages mean less per-filing signal value, though cumulative selling volume still matters.

"Notice value": Aggregate market value the filer wrote into the Form 144 — i.e. the size of the planned sale, not necessarily the executed dollars. Amendments (Form 144/A) and post-cancellation refilings can inflate this if you sum naively; the rollup above excludes filings with zero stated value.

Source & freshness: Sourced from public Form 144 filings. Refreshed daily; new filings typically appear here the morning after they are filed.

Filed Filer Role Shares Notice Value Planned Sale Broker Plan Link
2025-07-29 HILZ MARK T Officer, Director 4,416 $15.7K 2025-07-29 THE CHARLES SCHWAB CORPORATION 10b5-1 EDGAR
Notice value is the aggregate market value the filer states they intend to sell — not a confirmed transaction. Compare to Insider Activity (Form 4) to see which planned sales actually executed.
ETF Holders
# ETF Provider Weight $ Exposure ETF AUM As Of
Fundamentals

Quarterly filings sourced from SEC 10-Q / 10-K reports. TTM tiles aggregate the most recent four quarters; bars show the last ~12 quarters oldest → newest.

Metrics
  • Revenue — top-line sales. Look for consistent YoY growth; seasonal businesses need same-quarter comparisons (Q4 '24 vs Q4 '23).
  • Net Income — bottom-line profit after all expenses. Can be volatile from one-time items; red bars = net loss.
  • Diluted EPS — net income per share assuming options/converts are exercised. Direct input to the P/E ratio.
  • Operating Cash Flow — cash generated from core operations, before capex and financing. Harder to manipulate than net income; growing OCF is a quality signal.
How to read the bars
  • Sequential growth — quarter-over-quarter trend. Accelerating bars are a momentum signal.
  • YoY growth — compare to the same quarter a year earlier to remove seasonality.
  • Quality — OCF should roughly track Net Income over time. Large divergence (net income ≫ OCF) flags accruals risk.
  • Margins — scan the bar ratios: Net Income / Revenue tells you margin trend without needing a separate chart.

TTM (trailing-twelve-month) smooths seasonality and is used for the P/E calculation. Filings appear 30–90 days after the period closes.